{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:23:22Z","timestamp":1779157402424,"version":"3.51.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>SARS-COV-2 infection-induced excessive or uncontrolled cytokine storm may cause injury of host tissue or even death. However, the mechanism by which SARS-COV-2 causes the cytokine storm is unknown. Here, we demonstrated that SARS-COV-2 protein NSP9 promoted cytokine production by interacting with and activating TANK-binding kinase-1 (TBK1). With an rVSV-NSP9 virus infection model, we discovered that an NSP9-induced cytokine storm exacerbated tissue damage and death in mice. Mechanistically, NSP9 promoted the K63-linked ubiquitination and phosphorylation of TBK1, which induced the activation and translocation of IRF3, thereby increasing downstream cytokine production. Moreover, the E3 ubiquitin ligase Midline 1 (MID1) facilitated the K48-linked ubiquitination and degradation of NSP9, whereas virus infection inhibited the interaction between MID1 and NSP9, thereby inhibiting NSP9 degradation. Additionally, we identified Lys59 of NSP9 as a critical ubiquitin site involved in the degradation. These findings elucidate a previously unknown mechanism by which a SARS-COV-2 protein promotes cytokine storm and identifies a novel target for COVID-19 treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1211816","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T16:10:22Z","timestamp":1696263022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1"],"prefix":"10.3389","volume":"14","author":[{"given":"Yihua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dapeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e13525","DOI":"10.1111\/dth.13525","article-title":"Comprehensive overview of COVID-19 based on current evidence","volume":"33","author":"Kang","year":"2020","journal-title":"Dermatol Ther"},{"key":"B2","article-title":"SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview","volume":"28","author":"Rabaan","year":"2020","journal-title":"Infez Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000722","article-title":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study","volume":"133","author":"Ren","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-coV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3547","article-title":"Age-dependent dysregulation of innate immunity","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-coV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400593111","article-title":"Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection","volume":"111","author":"Teijaro","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-coV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41423-020-0514-8","article-title":"SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70","volume":"17","author":"Jiang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of type I interferon by SARS-coV-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.766922","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) membrane (M) and spike (S) proteins antagonize host type I interferon response","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1780953","article-title":"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists","volume":"9","author":"Yuen","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101161118","article-title":"Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein","volume":"118","author":"Hsu","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.9.2140","article-title":"The tripartite motif family identifies cell compartments","volume":"20","author":"Reymond","year":"2001","journal-title":"EMBO J"},{"key":"B23","article-title":"The MID1 protein is a central player during development and in disease","volume":"21","author":"Winter","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2407-14-52","article-title":"Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells","volume":"14","author":"Demir","year":"2014","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01103","article-title":"Hedgehog signal and genetic disorders","volume":"10","author":"Sasai","year":"2019","journal-title":"Front Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3049","article-title":"The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity","volume":"19","author":"Collison","year":"2013","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.215","article-title":"Shouts, whispers and the kiss of death: directional secretion in T cells","volume":"9","author":"Huse","year":"2008","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2417","article-title":"Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs","volume":"13","author":"Yan","year":"2012","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.04.006","article-title":"Human TBK1: A gatekeeper of neuroinflammation","volume":"22","author":"Ahmad","year":"2016","journal-title":"Trends Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-kappaB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.virol.2015.02.033","article-title":"Ubiquitination in the antiviral immune response","author":"Davis","year":"2015","journal-title":"Virology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3588","article-title":"E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1","volume":"17","author":"Song","year":"2016","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2012.72","article-title":"Ubiquitination and selective autophagy","volume":"20","author":"Shaid","year":"2013","journal-title":"Cell Death Differ"},{"key":"B37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cbpa.2018.05.004","article-title":"Targeted protein degradation and the enzymology of degraders","volume":"44","author":"Fisher","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbrc.2020.10.102","article-title":"Evolution patterns of SARS-CoV-2: Snapshot on its genome variants","volume":"538","author":"Giovanetti","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cytogfr.2020.11.001","article-title":"SARS-CoV-2: Targeted managements and vaccine development","volume":"58","author":"Bakhiet","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26254","article-title":"Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review","volume":"93","author":"Singh","year":"2021","journal-title":"J Med Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.01.033","article-title":"Structure and ubiquitination-dependent activation of TANK-binding kinase 1","volume":"3","author":"Tu","year":"2013","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00099-20","article-title":"The race between host antiviral innate immunity and the immune evasion strategies of herpes simplex virus 1","volume":"84","author":"Zhu","year":"2020","journal-title":"Microbiol Mol Biol Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02738","article-title":"Host immune responses and immune evasion strategies in african trypanosomiasis","volume":"10","author":"Onyilagha","year":"2019","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2018.10.043","article-title":"WSSV-host interaction: Host response and immune evasion","volume":"84","author":"Li","year":"2019","journal-title":"Fish Shellfish Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.64046","article-title":"Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development","volume":"17","author":"Qu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.05.007","article-title":"Cytosolic sensing of viruses","volume":"38","author":"Goubau","year":"2013","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00078","article-title":"Autophagy and ubiquitination in salmonella infection and the related inflammatory responses","volume":"8","author":"Wang","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-virology-092917-043323","article-title":"TRIM proteins and their roles in antiviral host defenses","volume":"5","author":"van Gent","year":"2018","journal-title":"Annu Rev Virol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-020-00150-8","article-title":"TRIM proteins in host defense and viral pathogenesis","volume":"7","author":"Giraldo","year":"2020","journal-title":"Curr Clin Microbiol Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.cell.2020.10.004","article-title":"SARS-coV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses","volume":"183","author":"Banerjee","year":"2020","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e2122897119","DOI":"10.1073\/pnas.2122897119","article-title":"SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis","volume":"119","author":"Qin","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662989","article-title":"SARS-coV-2 membrane protein inhibits type I interferon production through ubiquitin-mediated degradation of TBK1","volume":"12","author":"Sui","year":"2021","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.11.046","article-title":"NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells","volume":"586","author":"Makiyama","year":"2022","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1211816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T16:10:29Z","timestamp":1696263029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1211816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2023.1211816"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1211816","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"article-number":"1211816"}}